Listen

Description

Profusa Inc. has big plans for its tiny, injectable biosensors, a novel monitoring technology designed to be place under the skin for detecting and measuring body chemistry. In an exclusive podcast interview with Medtech Insight, Profusa's Chairman and CEO Ben Hwang talked about the technology, the upcoming market launch, and what's next for the company.